Dellaripa Advisory

Media strategy for
industries that can't
afford to get it wrong.

20 years of multichannel experience across pharma, financial services, and regulated industries. The judgment layer that makes AI actually useful.

Jason Dellaripa
Scroll

The short version.

I'm a marketing leader with 20 years of multichannel media experience. Healthcare and pharma are my home base, where I've led HCP and patient campaigns across rare disease, diagnostics, and specialty therapeutics, but I've spent significant time in financial services, CPG, education, and nonprofit as well.

That cross-industry range is intentional. Working across regulated verticals like pharma and financial services taught me how to build campaigns where compliance, measurement, and stakeholder complexity all intersect. Working in CPG and consumer brands taught me speed, scale, and performance rigor. The combination is what I bring to every engagement.

In pharma specifically, I work with cross-functional partners including medical affairs, market access, advocacy, and regulatory teams. I know how to work through MLR, develop compliant patient-facing materials, and build HCP targeting frameworks within platform and privacy constraints.

I've been consulting independently for 16 years alongside my full-time roles, across every industry I've touched. What started as side work became a practice. Dellaripa Advisory is the name I gave it when I decided to take it seriously.

20
Years in multichannel media strategy
16
Years consulting independently
$200M+
In media budgets managed annually
10+
Industry verticals served

Where this comes from.

Agency-side leadership across holding companies, independents, and my own consulting practice.

2025 – Present
VP, Integrated Media – Health & Wellness
Burson (WPP) • New York
Leading multichannel media strategy across pharma and health sciences accounts including Bayer, Amicus Therapeutics, and Exact Sciences. Overseeing campaigns across EHR, POC, programmatic, endemic, P2P, social, and search. Developing HCP and DTC segmentation frameworks including rare disease patient journeys.
Pharma Rare Disease HCP/DTC MLR Compliance
2024 – 2025
VP, Media Strategy & Growth
SocialScience • Philadelphia
Primary client contact for Stride Health, a leading ACA health insurance exchange, and io.net, a Web3 decentralized computing platform. Developed cross-channel strategies integrating SEO, paid media, and content. Built measurement and optimization infrastructure using GA4, Adobe, and Tableau.
ACA/Medicare Health Insurance Web3 Analytics
2022 – 2024
Vice President, Director
Starcom (Publicis Groupe) • Chicago
Led cross-functional media teams overseeing budgets up to $200MM annually across clients including Alcon, Planet Fitness, Kellogg's, HealthInsurance.com, and Blue Lantern Health. Managed DTC/HCP and CPG relationships, spearheaded business development, and drove innovation through advanced analytics.
$200MM Budgets Team Leadership Business Development
2007 – 2022
Partner, Digital Media Practice Lead
Blacklight Media & Analytics • New York
11+ years at an independent agency managing $50M+ in combined B2C and B2B marketing budgets. Led acquisition strategy for ING DIRECT, Capital One, OneMain Financial, BBVA, and UMGC. Built and led a global team crafting full-funnel campaigns across financial services and education.
FinServ Healthcare B2B/B2C Partner

Regulated industries.
Multichannel strategy.

The work lives where compliance meets performance, where the audience is segmented by condition, credential, or coverage tier, and where every claim needs substantiation.

Pharma & Biotech Media

Full-funnel HCP and DTC campaign strategy across rare disease, specialty therapeutics, and diagnostics. MLR-compliant creative development and patient journey mapping.

Financial Services

Acquisition strategy for banking, fintech, and insurance products. FINRA-aware campaign development and performance measurement across regulated channels.

Measurement & Analytics

Incrementality frameworks, attribution modeling, and platform evaluation. Translating platform metrics into the business outcomes your stakeholders actually care about.

Media Planning & Buying

Cross-channel planning across search, social, programmatic, endemic, EHR, POC, and emerging platforms. Budget allocation and optimization at scale.

Nonprofit & Education

Donor acquisition, enrollment campaigns, and growth strategy for organizations where mission drives the work and every dollar of spend has to be justified.

AI-Augmented Strategy

Using AI to compress the assembly layer of campaign work so more time goes to judgment, stakeholder management, and the decisions that actually move outcomes.

What the work actually delivered.

35%
Lower cost per lead

Restructured paid media across the health insurance exchange space, cutting lead generation costs by over a third within the first six months of engagement.

Health Insurance
+18%
Lead-to-enrollment conversion

Improved lead quality so more prospects actually converted to enrolled members. Better targeting and channel mix, same spend.

Health Insurance
Cost per $ deposited
Value-based acquisition

Most banks optimize media for account opens. I built a framework that tied back-end deposit data to platform performance, so we could optimize for the customers actually bringing in money, not just the ones signing up.

Financial Services
300%
Media investment scaled

Established baseline CAC within the first 90 days for early-stage companies, then scaled media investment 3x over six months while keeping CAC within +/- 10% of baseline.

Web3 & Digital Health

On AI, agencies, and
what comes next.

AI is changing the shape of agency work. The execution layer (pulling platform data, building reports, formatting decks) is getting compressed fast. The roles doing that work today will look different going forward, and the teams that adapt early will have a real advantage.

The strategic layer stays. Someone still has to know which data to trust, which recommendation is too simple, and which stakeholder is going to push back. In regulated industries, that judgment carries even more weight because getting it wrong means compliance risk, not just a bad performance week. AI frees up more time to focus there, which is where the real value has always been.

AI compresses the execution so more time goes to the decisions that actually matter. The teams that figure out how to use it well will have an edge. The ones that don't will fall behind.

From "The Practice You Already Built" // Dellaripa Advisory, 2026

Platform automation is moving in the same direction. The major ad platforms are building toward a model where they handle targeting, bidding, and creative rotation end-to-end. For small advertisers, that model is nearly here. For larger organizations running across multiple channels, geographies, and measurement frameworks, the platforms can't do it alone. The measurement layer is still fragmented, and making sense of that complexity is where experienced strategists add the most value.

Regulated industries add another layer on top of that. MLR review, compliance requirements, HCP targeting constraints, rare disease patient journeys, and indication-specific creative restrictions all require hands-on expertise. A media plan for a pharma brand can't be fully automated when every ad needs legal review and every claim needs substantiation. That complexity is where this work lives.

One more thing I'll say here: most budget conversations start in the wrong place. The question shouldn't be "how much should we spend?" It should be "how many customers do we need?" Work backward from there. If you know your target volume, your conversion rates at each stage, and what it costs to acquire a lead or a customer, the budget becomes an output of the math. That said, the math isn't perfectly linear. Acquisition costs tend to rise as you scale past your most efficient audiences, and your budget has to account for operational capacity too (sales bandwidth, onboarding, fulfillment). Customer lifetime value should also be part of the equation, because the acceptable cost to acquire someone worth $5,000 over time looks very different from someone worth $500. The point is that budget should follow from business goals and unit economics, with realistic assumptions baked in about how efficiency changes at scale.

From the people I've worked with.

Verticals I've worked across.

Pharmaceuticals
Biotech
Health Insurance / ACA
Financial Services
Rare Disease
Diagnostics
Nonprofit
Education
FinTech
Consumer Banking
Medicare
CPG
Web3

Let's talk.

If you're looking for someone who understands regulated industries, knows how to build and run multichannel campaigns at scale, and has the judgment to manage complex stakeholder environments, I'd welcome the conversation.